LeMaitre Vascular, Inc. (LMAT) News
Filter LMAT News Items
LMAT News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
LMAT News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest LMAT News From Around the Web
Below are the latest news stories about LEMAITRE VASCULAR INC that investors may wish to consider to help them evaluate LMAT as an investment opportunity.
4 Healthcare Stocks Rising More Than 50% in 2024 With Room to GrowMedical stocks are expected to reap the benefits of affordable health insurance plans, rising surgeries and widespread adoption of telehealth services in the days ahead. However, inflation and supply-chain woes may act as spoilsport. |
A Look At The Intrinsic Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)Key Insights Using the 2 Stage Free Cash Flow to Equity, LeMaitre Vascular fair value estimate is US$95.53 LeMaitre... |
LeMaitre Vascular Prices $150 Million Convertible Senior NotesBOSTON, Dec. 16, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (“LeMaitre”) (Nasdaq: LMAT) today announced the pricing of its offering of $150,000,000 aggregate principal amount of 2.50% Convertible Senior Notes due 2030 (the “notes”) in a private offering (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The issuance and sale of the notes is scheduled to settle on December 19, 2024, subject to customa |
LeMaitre Vascular Announces Proposed Convertible Senior Notes OfferingBOSTON, Dec. 16, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (“LeMaitre”) (Nasdaq: LMAT) today announced its intention to offer, subject to market and other conditions, $150,000,000 aggregate principal amount of Convertible Senior Notes due 2030 (the “notes”) in a private offering (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). LeMaitre also expects to grant the initial purchasers of the notes an o |
Inari Medical Stock Gets RS Rating UpgradeInari Medical shows improving price performance, earning an upgrade to its IBD Relative Strength Rating |
Novocure Stock Earns 96 RS RatingOn Tuesday, Novocure[ticker symb=NVCR] stock got a positive adjustment to its Relative Strength (RS) Rating, from 73 to 96. The oncology company had some good news Monday announcing success in its pancreatic cancer study. |
RMD vs. LMAT: Which Stock Is the Better Value Option?RMD vs. LMAT: Which Stock Is the Better Value Option? |
LeMaitre to Participate at Upcoming Investor Conferences in DecemberBURLINGTON, Mass., Nov. 25, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences in December. David Roberts, President, will present at the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024, at the Lotte New York Palace in New York City. The company’s presentation is scheduled for 3:30 PM EST. He is also scheduled to present at the Stifel “MedTech Madness” West Coast Bus Tour at the |
Should You Be Adding LeMaitre Vascular (NASDAQ:LMAT) To Your Watchlist Today?The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even... |
LeMaitre Vascular Third Quarter 2024 Earnings: Beats ExpectationsLeMaitre Vascular ( NASDAQ:LMAT ) Third Quarter 2024 Results Key Financial Results Revenue: US$54.8m (up 16% from 3Q... |